The headline numbers for DocuSign (DOCU) give insight into how the company performed in the quarter ended July 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DocuSign (DOCU) reached $74.04 at the closing of the latest trading day, reflecting a -1.03% change compared to its last close.
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
DocuSign's recent correction creates a Buy opportunity, hinging on cheap valuations and potential growth rebound from IAM product expansion. Growth concerns are valid due to slowing billings and fierce competition, but IAM's early adoption offers upside optionality over the next 1-2 years. Margins remain healthy, and further improvement is possible if IAM enhances differentiation and pricing power, though execution risk remains.
In the closing of the recent trading day, DocuSign (DOCU) stood at $71.7, denoting a +1.13% move from the preceding trading day.
In the most recent trading session, DocuSign (DOCU) closed at $73.84, indicating a -2.04% shift from the previous trading day.
Recently, Zacks.com users have been paying close attention to DocuSign (DOCU). This makes it worthwhile to examine what the stock has in store.
DOCU's deep Microsoft and Salesforce ties, 30% free cash flow margin, and 101% net retention boost its long-term value case.
DOCU's AI-powered IAM platform is transforming agreement workflows through deep Microsoft and Salesforce integrations.
DocuSign (DOCU) reached $79.37 at the closing of the latest trading day, reflecting a +2.25% change compared to its last close.
Recently, Zacks.com users have been paying close attention to DocuSign (DOCU). This makes it worthwhile to examine what the stock has in store.
Docusign, Inc. DOCU has been under considerable selling pressure, with the stock declining 15.4% year to date. This drop is in stark contrast to the 14% rally in its industry and the 6% gain in the Zacks S&P 500 composite, highlighting relative underperformance.